Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Total Current Assets
All assets expected to be converted to cash or used up within one year.
Total Current Assets history
Currency unavailable · from the balance sheet
No Total Current Assets data reported for this period type.
Total Current Assets vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.21B USD | +36.3% | +4.9% | 62.8% | |
| Jun 2026 | $659.21M USD | -14.4% | +12.2% | 93.6% | |
| Mar 2026 | $285.57M USD | — | — | 97.7% | |
| Mar 2026 | $172.18M USD | +82.8% | +94.8% | 99.3% | |
| Mar 2026 | $96.56M USD | +2.2% | -18.3% | 71.5% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +19.3% | +8.5% | 93.6% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.